Skip to main content
. 2016 Mar 8;7(15):20532–20548. doi: 10.18632/oncotarget.7978

Figure 4. Regulation of miR-24 levels by melatonin.

Figure 4

(A) HCT 116 and MCF-7 cells have been either pretreated or not with Luzindole 15 minutes before melatonin treatment and miR-24 levels have been quantified 72 h later by quantitative Real-Time PCR. Histograms show miR-24/RNU49 levels relative to untreated control. *p < 0,01. (B) HCT 116 cells have been treated with melatonin for 72 hours in the absence and in the presence of 5 μM SB202190. Histograms show miR-24/RNU49 levels relative to untreated control. *p < 0,01. (C) HCT 116 and MCF-7 cells were treated with melatonin for 72 h. Levels of expression of the indicated miRNAs were assessed by quantitative Real-Time PCR. (D) HCT 116 and MCF-7 cells were treated with melatonin for 72 h. Histograms show the ratio between pre-miR-24–1 and pri-miR-24–1 and the ratio between pre-miR-24–2 and pri-miR-24–2 levels. *p < 0,01.